US Patent 7335773 Intermediates for imidazonaphthyridines
Patent 7335773 was granted and assigned to Graceway Pharmaceuticals on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+332 characters)
Article
Patent abstract
Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07335773 Intermediates for imidazonaphthyridines US Patent 7335773 Intermediates for imidazonaphthyridines
Infobox
Patent Number
0733577300
Patent Number
733577300
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073357730
Date of Patent
February 26, 2008
0Patent Application Number
112760740
Date Filed
February 13, 2006
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073357730
Date of Patent
February 26, 2008
0Patent Application Number
112760740
Date Filed
February 13, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07335773 Intermediates for imidazonaphthyridines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07335773
Date of patent
February 26, 2008
Patent application number
11276074
Date Filed
February 13, 2006
Patent primary examiner
Find more entities like US Patent 7335773 Intermediates for imidazonaphthyridines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
